 |
|
Impact of Helicobacter pylori Eradication on the Risk of Incident Nonalcoholic Fatty Liver Disease: A Cohort Study
Ji Won Kim, Tae Jun Kim, Ji Eun Kim, Ji Eun Na, Hyuk Lee, Byung-Hoon Min, Jun Haeng Lee, Poong-Lyul Rhee, Jae J Kim
Korean J Helicobacter Up Gastrointest Res. 2022;22(2):131-138. Published online 2022 Apr 29 DOI: https://doi.org/10.7704/kjhugr.2021.0060
|
|
Citations to this article as recorded by
 Relationship between Helicobacter pylori infection and risk of metabolic dysfunction‐associated steatotic liver disease: An updated meta‐analysis
Alessandro Mantovani, Maria Giovanna Lando, Nicolò Borella, Enrico Scoccia, Barbara Pecoraro, Federico Gobbi, Zeno Bisoffi, Luca Valenti, Herbert Tilg, Christopher D. Byrne, Giovanni Targher
Liver International.2024;[Epub] CrossRef Relationship of Helicobacter pylori Infection with Nonalcoholic Fatty Liver Disease: A Meta-Analysis
Guangqin Xu, Shaoze Ma, Liyan Dong, Nahum Mendez-Sanchez, Hongyu Li, Xingshun Qi, Alessandro Granito
Canadian Journal of Gastroenterology and Hepatology.2023; 2023: 1. CrossRef The possible role of Helicobacter pylori in liver diseases
Mahnaz Mohammadi, Adeleh Attar, Maryam Mohammadbeigi, Amir Peymani, Shahin Bolori, Fatemeh Fardsanei
Archives of Microbiology.2023;[Epub] CrossRef Can Helicobacter pylori Eradication Therapy Reduce the Incidence of Nonalcoholic Fatty Liver Disease?
Sun Hyung Kang
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2022; 22(2): 81. CrossRef
|